Ivani Rosa de Meneses
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ivani Rosa de Meneses has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Alex Gutterres Taranto
Laboratory of Bioinformatics and Drug Design, Department of Biotechnology, Federal University of São João del Rei, Praça Dom Helvécio, 74, Dom Bosco, Minas Gerais, São João del-Rei 36301-160, MG, Brazil
1 shared publication - Brayan Jonas Mano-Sousa
Federal University of São João del Rei
1 shared publication - Bruna Cristina Alves
Campus Centro-Oeste, Universidade Federal de São João del-Rei, Divinópolis, Minas Gerais, Brazil
1 shared publication - Christiane Fátima Oliveira
Universidade Federal de São João del-Rei
1 shared publication - Joaquim Maurício Duarte-Almeida
Plant Cell Culture Laboratory, Federal University of São João del Rei (UFSJ), Chanadour, Divinópolis, Brazil
1 shared publication - Paulo Batista de Carvalho
Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX 78212, USA
1 shared publication
Latest Publications
- Open Access
- 6 June 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (8)
Can propolis and their compounds be efficacy in the treatment of coronavirus disease 2019 (COVID-19)? A systematic review
Despite the advancement of vaccination and the reduction in the number of deaths, there is still the emergence of new variants, such as the omicron of SARS-CoV-2 (COVID-19). In this sense, new natural antiviral therapies are highly explored. One of these products, propolis, have shown promising results against COVID-19, including the inhibition of the binding between the coronavirus and ACE2. This systematic review aimed to gather a summary of scientific evidence existing on the effective of the therapeutic use of propolis and their components in the treatment of COVID-19. The protocol for the present systematic review was registered on the PROSPERO (CRD42021267016). In this study, we analyzed 185 articles, selecting 13 of them. Some phenolic compounds and flavonoids, such as artepillin C, hesperetin, CAPE and rutin, were widely cited, as they have great potential for binding with the molecular targets of SARS-CoV-2. Some clinical studies that evaluated the effects of propolis against COVID-19 were included, and confirmed the effectiveness of propolis and its components. The results of this review demonstrate the effectiveness of using propolis and their components in the treatment of COVID-19 due to its antiviral activities. Additionally, the anti-inflammatory and immunomodulatory properties can help to patients with COVID-19.
- 6 June 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (8)
Open AccessCan propolis and their compounds be efficacy in the treatment of coronavirus disease 2019 (COVID-19)? A systematic review
Despite the advancement of vaccination and the reduction in the number of deaths, there is still the emergence of new variants, such as the omicron of SARS-CoV-2 (COVID-19). In this sense, new natural antiviral therapies are highly explored. One of these products, propolis, have shown promising results against COVID-19, including the inhibition of the binding between the coronavirus and ACE2. This systematic review aimed to gather a summary of scientific evidence existing on the effective of the therapeutic use of propolis and their components in the treatment of COVID-19. The protocol for the present systematic review was registered on the PROSPERO (CRD42021267016). In this study, we analyzed 185 articles, selecting 13 of them. Some phenolic compounds and flavonoids, such as artepillin C, hesperetin, CAPE and rutin, were widely cited, as they have great potential for binding with the molecular targets of SARS-CoV-2. Some clinical studies that evaluated the effects of propolis against COVID-19 were included, and confirmed the effectiveness of propolis and its components. The results of this review demonstrate the effectiveness of using propolis and their components in the treatment of COVID-19 due to its antiviral activities. Additionally, the anti-inflammatory and immunomodulatory properties can help to patients with COVID-19.